Directed evolution of hydrolases for prevention of G-type nerve agent intoxication

Nature Chemical Biology

Volumn 7, Issue 2, 2011, Pages 120-125

  Gupta, Rinkoo D ^a   Goldsmith, Moshe ^a   Ashani, Yacov ^a   Simo, Yair ^a   Mullokandov, Gavriel ^a   Bar, Hagit ^a   Ben David, Moshe ^a   Leader, Haim ^a   Margalit, Raanan ^a   Silman, Israel ^a   Sussman, Joel L ^a   Tawfik, Dan S ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; ARYLDIALKYLPHOSPHATASE 1; COUMARIN; CYCLOSARIN; HYDROLASE; ORGANOPHOSPHATE;

ADOLESCENT; ANIMAL EXPERIMENT; ARTICLE; CATALYSIS; CONTROLLED STUDY; DEGRADATION; EMULSION; ENZYME ACTIVITY; ENZYME ENGINEERING; ENZYME INACTIVATION; HIGH THROUGHPUT SCREENING; HYDROLYSIS; IN VIVO STUDY; INTOXICATION; MALE; MOUSE; MUTAGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROPHYLAXIS;

EID: 78751573957     PISSN: 15524450     EISSN: 15524469     Source Type: Journal    
DOI: 10.1038/nchembio.510     Document Type: Article

References (28)

1. Doctor, B.P. & Saxena, A. Bioscavengers for the protection of humans against organophosphate toxicity. Chem. Biol. Interact. 157-158, 167-171 (2005).
2. Lenz, D.E. et al. Stoichiometric and catalytic scavengers as protection against nerve agent toxicity: a mini review. Toxicology 233, 31-39 (2007).
3. Ashani, Y. & Pistinner, S. Estimation of the upper limit of human butyrylcholinesterase dose required for protection against organophosphates toxicity: a mathematically based toxicokinetic model. Toxicol. Sci. 77, 358-367 (2004).
4. diTargiani, R.C., Chandrasekaran, L., Belinskaya, T. & Saxena, A. In search of a catalytic bioscavenger for the prophylaxis of nerve agent toxicity. Chem. Biol. Interact. 187, 349-354 (2010).
5. Ghanem, E. & Raushel, F.M. Detoxification of organophosphate nerve agents by bacterial phosphotriesterase. Toxicol. Appl. Pharmacol. 207, 459-470 (2005).
6. Mee-Hie Cho, C., Mulchandani, A. & Chen, W. Functional analysis of organophosphorus hydrolase variants with high degradation activity towards organophosphate pesticides. Protein Eng. Des. Sel. 19, 99-105 (2006).
7. Melzer, M. et al. Reversed enantioselectivity of diisopropyl fluorophosphatase against organophosphorus nerve agents by rational design. J. Am. Chem. Soc. 131, 17226-17232 (2009).
8. Tsai, P.C. et al. Stereoselective hydrolysis of organophosphate nerve agents by the bacterial phosphotriesterase. Biochemistry 49, 7978-7987 (2010).
9. Ashani, Y., Rothschild, N., Segall, Y., Levanon, D. & Raveh, L. Prophylaxis against organophosphate poisoning by an enzyme hydrolysing organophosphorus compounds in mice. Life Sci. 49, 367-374 (1991).
10. Broomfield, C.A. A purified recombinant organophosphorus acid anhydrase protects mice against soman. Chem. Biol. Interact. 87, 279-284 (1993).
11. Li, W.F., Furlong, C.E. & Costa, L.G. Paraoxonase protects against chlorpyrifos toxicity in mice. Toxicol. Lett. 76, 219-226 (1995).
12. Kassa, J., Karasova, J.Z., Caisberger, F. & Bajgar, J. The influence of combinations of oximes on the reactivating and therapeutic efficacy of antidotal treatment of soman poisoning in rats and mice. Toxicol. Mech. Methods 19, 547-551 (2009).
13. Harvey, S.P. et al. Stereospecificity in the enzymatic hydrolysis of cyclosarin (GF). Enzyme Microb. Technol. 37, 547-555 (2005).
14. Li, W.S., Lum, K.T., Chen-Goodspeed, M., Sogorb, M.A. & Raushel, F.M. Stereoselective detoxification of chiral sarin and soman analogues by phosphotriesterase. Bioorg. Med. Chem. 9, 2083-2091 (2001).
15. Amitai, G. et al. Enhanced stereoselective hydrolysis of toxic organophosphates by directly evolved variants of mammalian serum paraoxonase. FEBS J. 273, 1906-1919 (2006).
16. Aharoni, A. et al. Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization. Proc. Natl. Acad. Sci. USA 101, 482-487 (2004).
17. Gaidukov, L. et al. In vivo administration of BL-3050: highly stable engineered PON1-HDL complexes. BMC Clin. Pharmacol. 9, 18 (2009).
18. Ashani, Y. et al. Stereo-specific synthesis of analogs of nerve agents and their utilization for selection and characterization of paraoxonase (PON1) catalytic scavengers. Chem. Biol. Interact. 187, 362-369 (2010).
19. Gupta, R.D. & Tawfik, D.S. Directed enzyme evolution via small and effective neutral drift libraries. Nat. Methods 5, 939-942 (2008).
20. Aharoni, A., Amitai, G., Bernath, K., Magdassi, S. & Tawfik, D.S. High-throughput screening of enzyme libraries: thiolactonases evolved by fluorescence-activated sorting of single cells in emulsion compartments. Chem. Biol. 12, 1281-1289 (2005).
21. Mastrobattista, E. et al. High-throughput screening of enzyme libraries: in vitro evolution of a beta-galactosidase by fluorescence-activated sorting of double emulsions. Chem. Biol. 12, 1291-1300 (2005).
22. Herman, A. & Tawfik, D.S. Incorporating Synthetic Oligonucleotides via Gene Reassembly (ISOR): a versatile tool for generating targeted libraries. Protein Eng. Des. Sel. 20, 219-226 (2007).
23. Romano, J.A., Lukey, B.J. & Salem, H. Chemical warfare agents: chemistry, pharmacology, toxicology, and therapeutics. (CRC Press, Boca Raton, 2008).
24. Amitai, G. et al. Asymmetric fluorogenic organophosphates for the development of active organophosphate hydrolases with reversed stereoselectivity. Toxicology 233, 187-198 (2007).
25. Luo, C., Chambers, C., Yang, Y. & Saxena, A. Mechanism for potent reactivation ability of H oximes analyzed by reactivation kinetic studies with cholinesterases from different species. Chem. Biol. Interact. 187, 185-190 (2010).
26. Reetz, M.T., Kahakeaw, D. & Lohmer, R. Addressing the numbers problem in directed evolution. ChemBioChem 9, 1797-1804 (2008).
27. Fox, R.J. et al. Improving catalytic function by ProSAR-driven enzyme evolution. Nat. Biotechnol. 25, 338-344 (2007).
28. Shapiro, M.G. et al. Directed evolution of a magnetic resonance imaging contrast agent for noninvasive imaging of dopamine. Nat. Biotechnol. 28, 264-270 (2010).